Bicycle therapeutics plc announces executive changes

Bicycle therapeutics plc announced the appointment of nigel crockett, ph.d., as the company’s chief business officer, replacing peter leone. dr. crockett has more than 25 years of experience in global business development for biopharmaceutical companies. dr. crockett was most recently a founding partner at tukan partners ltd. prior to tukan, he held commercial and business development roles within the life sciences sector, including as vice president, business development at astex therapeutics. dr. crockett has executed more than 50 major in- and out-licensing deals as well as several company acquisitions.
BCYC Ratings Summary
BCYC Quant Ranking